CLINICAL_TRIALS
trial_result
· 2021-04-06
Clinical Trial Update: AGN-242428 in the Treatment of Plaque Psoriasis [Phase 2]
Summary
Phase 2 trial of AGN-242428 for plaque psoriasis was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vitae Pharmaceuticals, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: TERMINATED | Results posted: 2021-04-06